Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
APL-2, a complement C3 inhibitor, may potentially reduce both intravascular and extravascular hemolysis in patients with paroxysmal nocturnal hemoglobinuria
PaperCitations, authors & open-access status
APL-2, a complement C3 inhibitor, may potentially reduce both intravascular and extravascular hemolysis in patients with paroxysmal nocturnal hemoglobinuria is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 8 citations, 2017 year and closed oa status.
8
Citations
2017
Year
closed
OA Status